Quarterly Update & Appendix 4C
• Type C meeting granted with US FDA to discuss ATL1102 in DMD
• Paediatric Investigation Plan for ATL1102 in DMD submitted to EMA
• Manufacture of clinical supplies in progress
• Dr Charmaine Gittleson appointed as a Non-Executive Director
- Forums
- Charts
- Chart
Quarterly Update & Appendix 4C• Type C meeting granted with US...
-
-
- There are more pages in this discussion • 2,377 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.1¢ | $47.41K | 578.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 142694 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 104529 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 142694 | 0.081 |
4 | 100252 | 0.080 |
1 | 6500 | 0.079 |
2 | 212658 | 0.078 |
2 | 85000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 104529 | 2 |
0.083 | 214564 | 2 |
0.084 | 67142 | 2 |
0.085 | 90800 | 2 |
0.086 | 106100 | 2 |
Last trade - 14.00pm 12/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |